Samsung to Invest $100 Mn in AI-Powered Medical Imaging Startup Exo
The funding round is reportedly being led by Sands Capital, Bold Capital, and Qubit Health Capital. As part of the deal, Omar Ishrak, chairman of Qubit Health, is expected to join Exo’s board.
Samsung’s venture investment arm is in talks to invest up to $100 million in California-based medical imaging startup Exo.
The funding round is reportedly being led by Sands Capital, Bold Capital, and Qubit Health Capital.
As part of the deal, Omar Ishrak, chairman of Qubit Health, is expected to join Exo’s board.
Founded in 2015, Exo develops handheld ultrasound devices that combine artificial intelligence, advanced medical imaging, and silicon technology.
The devices can connect directly to smartphones, enabling healthcare professionals to perform critical scans like lung exams and echocardiograms on the go. Scan results are shared via a dedicated app.
So far, Exo has raised over $320 million from investors including RA Capital Management, BlackRock, Intel, Sony, Sands Capital, and Avidity Partners. Its most recent major funding was a $220 million Series C round in 2021.
Sources also indicated that Exo is in advanced discussions with Samsung Medison, Samsung’s medical equipment division specializing in ultrasound diagnostics and digital imaging, for a potential partnership aimed at expanding ultrasound solutions globally.
